Manipal Health shares jump 13% on debut after ₹9,275 crore IPO

Manipal Health Enterprises made a strong debut on the Indian stock market, with its shares closing nearly 13% above the initial public offering (IPO) price. The listing has placed one of India’s largest hospital networks firmly on investors’ radar and comes as healthcare continues to attract significant private and public market investment.

The company’s shares were listed on the BSE at ₹655, an 11% premium to the IPO issue price of ₹590. The stock moved higher during the session, touching an intraday high of ₹676 before closing at ₹666. On the NSE, the shares reached ₹675 and ended at ₹663, more than 12% above the issue price.

The strong debut gave Manipal Health a market value of nearly ₹88,000 crore. At the end of the first trading session, its market capitalisation stood at around ₹87,696 crore on the BSE and ₹87,229 crore on the NSE. The company had raised ₹9,275 crore through the IPO, making it one of India’s largest healthcare public offerings.

Investor interest in the issue was strong overall. The IPO received bids for around 44.3 crore shares against nine crore shares on offer, resulting in an overall subscription of 4.92 times. Qualified institutional buyers showed the strongest demand, with their portion subscribed 8.25 times. The employee category was subscribed 2.19 times, while the non-institutional investor portion was subscribed 1.02 times.

Retail investors were more cautious. The retail portion received bids for 0.93 times the shares reserved for the category, meaning it fell slightly short of full subscription. The contrast between institutional and retail demand shows how the IPO attracted stronger interest from large investors than individual applicants.

Manipal Health operates 49 hospitals with 13,037 beds across 14 states and Union territories, according to data cited by The Times of India. The company is the largest pan-India multi-speciality hospital network by bed capacity, based on a CRISIL report cited in the publication.

The listing is important for India’s equity market because it gives investors another listed healthcare business through which to gain exposure to the country’s growing demand for private medical services. Rising healthcare needs, expansion of hospital networks and greater spending on specialised treatment have made the sector an important area for investors.

The IPO also comes at a time when India’s healthcare market is seeing wider investment activity. FinanceAsia reported that Manipal Health’s debut followed a ₹92.75 billion, or about $974.9 million, IPO, while private equity firm KKR also agreed to acquire Hyderabad-based Medicover Hospitals India for €1.2 billion. The deals point to continued investor interest in India’s private healthcare sector.

For the wider market, Manipal Health’s debut highlights the appetite for established businesses with large operating networks and long-term growth opportunities. However, a strong listing does not guarantee future share-price performance. Investors will continue to watch the company’s financial results, expansion plans, debt levels and ability to grow earnings after its market debut.

For investors, the key takeaway is that Manipal Health has entered the public market with strong institutional interest and a sizeable valuation. Its performance in the coming quarters will show whether the hospital chain can turn that initial market enthusiasm into sustained shareholder value.